Fisher & Paykel Healthcare Corporation Limited (ASX:FPH) is a health care equipment and services company which was listed on the Australian Securities Exchange (ASX) on 21 November 2001, under the ticker code FPH. Headquartered in East Tamaki, the company designs, manufactures and markets systems and products which are used in chronic and acute respiratory surgery, treatment, and care of obstructive sleep apnea. The company is also listed on the New Zealand Stock Exchange. The medical technologies and devices offered by the company help clinicians deliver patient care. The devices assist the patients in transitioning into less-acute care settings, avoiding serious conditions and recovering quickly. The therapies and products offered by the group help the patients to be treated at their preferred place, like a home rather than a hospital. The company marked its beginning in 1969 with the development of the first prototype respiratory humidifier. Initially, the company was engaged in producing products for invasive ventilation; later, it expanded its offerings to other clinical applications that includes nasal high flow therapy. Products for non-invasive ventilation and treatment of obstructive sleep apnea. The product portfolio was also expanded to address the need of children and infants.